Phase 1Completed

A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males (DDI)

An Open-label Exploratory Study of the Pharmacokinetic Interaction of CXA-10 Administered to Steady State With Pravastatin and Vytorin® (Simvastatin and Ezetimibe) in Healthy Males

Sponsor
Complexa, Inc. (Industry)
Enrollment
10 enrolled
Conditions
Acute Kidney Injury
Interventions
CXA-10; pravastatin; Vytorin® (combination of simvastatin and ezetimibe)
Ages
adults
Registry
NCT02547402

Full record on ClinicalTrials.gov

From the registry

This is an exploratory study in a small, well controlled group of healthy subjects to explore the effect of CXA-10 on pravastatin and Vytorin® (combination of simvastatin and ezetimibe).

Primary outcomes

  • Maximum Plasma Concentration [Cmax]

History

  1. Last registry update

  2. Study completion

  3. Primary completion

  4. Started

  5. Registered